 | • レポートコード：QYR2104Z1279 • 出版社/出版日：QYResearch / 2021年4月15日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、88ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、キメラ抗体のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（IgG、IgM、IgA、その他）、用途別市場規模（病院、科学研究、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・キメラ抗体の市場動向 ・企業の競争状況、市場シェア ・キメラ抗体の種類別市場規模（IgG、IgM、IgA、その他） ・キメラ抗体の用途別市場規模（病院、科学研究、その他） ・キメラ抗体の北米市場規模2016-2027（アメリカ、カナダ） ・キメラ抗体のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・キメラ抗体のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・キメラ抗体の中南米市場規模2016-2027（メキシコ、ブラジル） ・キメラ抗体の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Creative-Biolabs、Biotem、OmniAb Technology） ・結論 |
Chimeric antibody is the first genetically engineered antibody to be produced successfully. It is made by splicing the V region gene of mouse antibody and the C region gene of human antibody into chimeric gene, and then inserting the vector, transfecting the antibody molecule expressed in myeloma tissue. Because it reduces the murine component, it reduces the adverse reactions caused by murine antibody and helps to improve the curative effect.
Market Analysis and Insights: Global Chimeric Antibody Market
The global Chimeric Antibody market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Chimeric Antibody market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Chimeric Antibody market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Chimeric Antibody market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Chimeric Antibody market.
Global Chimeric Antibody Scope and Market Size
Chimeric Antibody market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Chimeric Antibody market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
IgG
IgM
IgA
Others
Segment by Application
Hospital
Scientific Research
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Creative-Biolabs
Biotem
OmniAb Technology
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chimeric Antibody Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 IgG
1.2.3 IgM
1.2.4 IgA
1.2.5 Others
1.3 Market by Application
1.3.1 Global Chimeric Antibody Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Scientific Research
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Chimeric Antibody Market Perspective (2016-2027)
2.2 Chimeric Antibody Growth Trends by Regions
2.2.1 Chimeric Antibody Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Chimeric Antibody Historic Market Share by Regions (2016-2021)
2.2.3 Chimeric Antibody Forecasted Market Size by Regions (2022-2027)
2.3 Chimeric Antibody Industry Dynamic
2.3.1 Chimeric Antibody Market Trends
2.3.2 Chimeric Antibody Market Drivers
2.3.3 Chimeric Antibody Market Challenges
2.3.4 Chimeric Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chimeric Antibody Players by Revenue
3.1.1 Global Top Chimeric Antibody Players by Revenue (2016-2021)
3.1.2 Global Chimeric Antibody Revenue Market Share by Players (2016-2021)
3.2 Global Chimeric Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Chimeric Antibody Revenue
3.4 Global Chimeric Antibody Market Concentration Ratio
3.4.1 Global Chimeric Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chimeric Antibody Revenue in 2020
3.5 Chimeric Antibody Key Players Head office and Area Served
3.6 Key Players Chimeric Antibody Product Solution and Service
3.7 Date of Enter into Chimeric Antibody Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Chimeric Antibody Breakdown Data by Type
4.1 Global Chimeric Antibody Historic Market Size by Type (2016-2021)
4.2 Global Chimeric Antibody Forecasted Market Size by Type (2022-2027)
5 Chimeric Antibody Breakdown Data by Application
5.1 Global Chimeric Antibody Historic Market Size by Application (2016-2021)
5.2 Global Chimeric Antibody Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Chimeric Antibody Market Size (2016-2027)
6.2 North America Chimeric Antibody Market Size by Type
6.2.1 North America Chimeric Antibody Market Size by Type (2016-2021)
6.2.2 North America Chimeric Antibody Market Size by Type (2022-2027)
6.2.3 North America Chimeric Antibody Market Size by Type (2016-2027)
6.3 North America Chimeric Antibody Market Size by Application
6.3.1 North America Chimeric Antibody Market Size by Application (2016-2021)
6.3.2 North America Chimeric Antibody Market Size by Application (2022-2027)
6.3.3 North America Chimeric Antibody Market Size by Application (2016-2027)
6.4 North America Chimeric Antibody Market Size by Country
6.4.1 North America Chimeric Antibody Market Size by Country (2016-2021)
6.4.2 North America Chimeric Antibody Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Chimeric Antibody Market Size (2016-2027)
7.2 Europe Chimeric Antibody Market Size by Type
7.2.1 Europe Chimeric Antibody Market Size by Type (2016-2021)
7.2.2 Europe Chimeric Antibody Market Size by Type (2022-2027)
7.2.3 Europe Chimeric Antibody Market Size by Type (2016-2027)
7.3 Europe Chimeric Antibody Market Size by Application
7.3.1 Europe Chimeric Antibody Market Size by Application (2016-2021)
7.3.2 Europe Chimeric Antibody Market Size by Application (2022-2027)
7.3.3 Europe Chimeric Antibody Market Size by Application (2016-2027)
7.4 Europe Chimeric Antibody Market Size by Country
7.4.1 Europe Chimeric Antibody Market Size by Country (2016-2021)
7.4.2 Europe Chimeric Antibody Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Chimeric Antibody Market Size (2016-2027)
8.2 Asia-Pacific Chimeric Antibody Market Size by Type
8.2.1 Asia-Pacific Chimeric Antibody Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Chimeric Antibody Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Chimeric Antibody Market Size by Type (2016-2027)
8.3 Asia-Pacific Chimeric Antibody Market Size by Application
8.3.1 Asia-Pacific Chimeric Antibody Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Chimeric Antibody Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Chimeric Antibody Market Size by Application (2016-2027)
8.4 Asia-Pacific Chimeric Antibody Market Size by Region
8.4.1 Asia-Pacific Chimeric Antibody Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Chimeric Antibody Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Chimeric Antibody Market Size (2016-2027)
9.2 Latin America Chimeric Antibody Market Size by Type
9.2.1 Latin America Chimeric Antibody Market Size by Type (2016-2021)
9.2.2 Latin America Chimeric Antibody Market Size by Type (2022-2027)
9.2.3 Latin America Chimeric Antibody Market Size by Type (2016-2027)
9.3 Latin America Chimeric Antibody Market Size by Application
9.3.1 Latin America Chimeric Antibody Market Size by Application (2016-2021)
9.3.2 Latin America Chimeric Antibody Market Size by Application (2022-2027)
9.3.3 Latin America Chimeric Antibody Market Size by Application (2016-2027)
9.4 Latin America Chimeric Antibody Market Size by Country
9.4.1 Latin America Chimeric Antibody Market Size by Country (2016-2021)
9.4.2 Latin America Chimeric Antibody Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chimeric Antibody Market Size (2016-2027)
10.2 Middle East & Africa Chimeric Antibody Market Size by Type
10.2.1 Middle East & Africa Chimeric Antibody Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Chimeric Antibody Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Chimeric Antibody Market Size by Type (2016-2027)
10.3 Middle East & Africa Chimeric Antibody Market Size by Application
10.3.1 Middle East & Africa Chimeric Antibody Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Chimeric Antibody Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Chimeric Antibody Market Size by Application (2016-2027)
10.4 Middle East & Africa Chimeric Antibody Market Size by Country
10.4.1 Middle East & Africa Chimeric Antibody Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Chimeric Antibody Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Creative-Biolabs
11.1.1 Creative-Biolabs Company Details
11.1.2 Creative-Biolabs Business Overview
11.1.3 Creative-Biolabs Chimeric Antibody Introduction
11.1.4 Creative-Biolabs Revenue in Chimeric Antibody Business (2016-2021)
11.1.5 Creative-Biolabs Recent Development
11.2 Biotem
11.2.1 Biotem Company Details
11.2.2 Biotem Business Overview
11.2.3 Biotem Chimeric Antibody Introduction
11.2.4 Biotem Revenue in Chimeric Antibody Business (2016-2021)
11.2.5 Biotem Recent Development
11.3 OmniAb Technology
11.3.1 OmniAb Technology Company Details
11.3.2 OmniAb Technology Business Overview
11.3.3 OmniAb Technology Chimeric Antibody Introduction
11.3.4 OmniAb Technology Revenue in Chimeric Antibody Business (2016-2021)
11.3.5 OmniAb Technology Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Chimeric Antibody Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of IgG
Table 3. Key Players of IgM
Table 4. Key Players of IgA
Table 5. Key Players of Others
Table 6. Global Chimeric Antibody Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Chimeric Antibody Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Chimeric Antibody Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Chimeric Antibody Market Share by Regions (2016-2021)
Table 10. Global Chimeric Antibody Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Chimeric Antibody Market Share by Regions (2022-2027)
Table 12. Chimeric Antibody Market Trends
Table 13. Chimeric Antibody Market Drivers
Table 14. Chimeric Antibody Market Challenges
Table 15. Chimeric Antibody Market Restraints
Table 16. Global Chimeric Antibody Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Chimeric Antibody Market Share by Players (2016-2021)
Table 18. Global Top Chimeric Antibody Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chimeric Antibody as of 2020)
Table 19. Ranking of Global Top Chimeric Antibody Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Chimeric Antibody Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Chimeric Antibody Product Solution and Service
Table 23. Date of Enter into Chimeric Antibody Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Chimeric Antibody Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Chimeric Antibody Revenue Market Share by Type (2016-2021)
Table 27. Global Chimeric Antibody Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Chimeric Antibody Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Chimeric Antibody Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Chimeric Antibody Revenue Market Share by Application (2016-2021)
Table 31. Global Chimeric Antibody Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Chimeric Antibody Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Chimeric Antibody Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Chimeric Antibody Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Chimeric Antibody Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Chimeric Antibody Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Chimeric Antibody Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Chimeric Antibody Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Chimeric Antibody Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Chimeric Antibody Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Chimeric Antibody Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Chimeric Antibody Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Chimeric Antibody Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Chimeric Antibody Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Chimeric Antibody Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Chimeric Antibody Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Chimeric Antibody Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Chimeric Antibody Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Chimeric Antibody Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Chimeric Antibody Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Chimeric Antibody Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Chimeric Antibody Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Chimeric Antibody Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Chimeric Antibody Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Chimeric Antibody Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Chimeric Antibody Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Chimeric Antibody Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Chimeric Antibody Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Chimeric Antibody Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Chimeric Antibody Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Chimeric Antibody Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Chimeric Antibody Market Size by Country (2022-2027) & (US$ Million)
Table 63. Creative-Biolabs Company Details
Table 64. Creative-Biolabs Business Overview
Table 65. Creative-Biolabs Chimeric Antibody Product
Table 66. Creative-Biolabs Revenue in Chimeric Antibody Business (2016-2021) & (US$ Million)
Table 67. Creative-Biolabs Recent Development
Table 68. Biotem Company Details
Table 69. Biotem Business Overview
Table 70. Biotem Chimeric Antibody Product
Table 71. Biotem Revenue in Chimeric Antibody Business (2016-2021) & (US$ Million)
Table 72. Biotem Recent Development
Table 73. OmniAb Technology Company Details
Table 74. OmniAb Technology Business Overview
Table 75. OmniAb Technology Chimeric Antibody Product
Table 76. OmniAb Technology Revenue in Chimeric Antibody Business (2016-2021) & (US$ Million)
Table 77. OmniAb Technology Recent Development
Table 78. Research Programs/Design for This Report
Table 79. Key Data Information from Secondary Sources
Table 80. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chimeric Antibody Market Share by Type: 2020 VS 2027
Figure 2. IgG Features
Figure 3. IgM Features
Figure 4. IgA Features
Figure 5. Others Features
Figure 6. Global Chimeric Antibody Market Share by Application: 2020 VS 2027
Figure 7. Hospital Case Studies
Figure 8. Scientific Research Case Studies
Figure 9. Others Case Studies
Figure 10. Chimeric Antibody Report Years Considered
Figure 11. Global Chimeric Antibody Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Chimeric Antibody Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Chimeric Antibody Market Share by Regions: 2020 VS 2027
Figure 14. Global Chimeric Antibody Market Share by Regions (2022-2027)
Figure 15. Global Chimeric Antibody Market Share by Players in 2020
Figure 16. Global Top Chimeric Antibody Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chimeric Antibody as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Chimeric Antibody Revenue in 2020
Figure 18. Global Chimeric Antibody Revenue Market Share by Type (2016-2021)
Figure 19. Global Chimeric Antibody Revenue Market Share by Type (2022-2027)
Figure 20. North America Chimeric Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Chimeric Antibody Market Share by Type (2016-2027)
Figure 22. North America Chimeric Antibody Market Share by Application (2016-2027)
Figure 23. North America Chimeric Antibody Market Share by Country (2016-2027)
Figure 24. United States Chimeric Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Chimeric Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Chimeric Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Chimeric Antibody Market Share by Type (2016-2027)
Figure 28. Europe Chimeric Antibody Market Share by Application (2016-2027)
Figure 29. Europe Chimeric Antibody Market Share by Country (2016-2027)
Figure 30. Germany Chimeric Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Chimeric Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Chimeric Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Chimeric Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Chimeric Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Chimeric Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Chimeric Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Chimeric Antibody Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Chimeric Antibody Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Chimeric Antibody Market Share by Region (2016-2027)
Figure 40. China Chimeric Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Chimeric Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Chimeric Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Chimeric Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Chimeric Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Chimeric Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Chimeric Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Chimeric Antibody Market Share by Type (2016-2027)
Figure 48. Latin America Chimeric Antibody Market Share by Application (2016-2027)
Figure 49. Latin America Chimeric Antibody Market Share by Country (2016-2027)
Figure 50. Mexico Chimeric Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Chimeric Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Chimeric Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Chimeric Antibody Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Chimeric Antibody Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Chimeric Antibody Market Share by Country (2016-2027)
Figure 56. Turkey Chimeric Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Chimeric Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Chimeric Antibody Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Creative-Biolabs Revenue Growth Rate in Chimeric Antibody Business (2016-2021)
Figure 60. Biotem Revenue Growth Rate in Chimeric Antibody Business (2016-2021)
Figure 61. OmniAb Technology Revenue Growth Rate in Chimeric Antibody Business (2016-2021)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed